IRIS
PAPPONE, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.251
NA - Nord America 5.004
EU - Europa 3.023
SA - Sud America 2.713
AF - Africa 182
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 5
Totale 18.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.784
SG - Singapore 3.200
BR - Brasile 2.278
CN - Cina 1.679
HK - Hong Kong 1.039
SE - Svezia 961
VN - Vietnam 757
RU - Federazione Russa 419
IT - Italia 324
RO - Romania 269
DE - Germania 254
IE - Irlanda 223
FI - Finlandia 203
AR - Argentina 175
GB - Regno Unito 103
IN - India 96
MX - Messico 94
ID - Indonesia 93
BD - Bangladesh 83
EC - Ecuador 76
CA - Canada 74
ZA - Sudafrica 65
AT - Austria 57
CO - Colombia 47
IQ - Iraq 46
PL - Polonia 38
TR - Turchia 37
JP - Giappone 33
PY - Paraguay 32
NL - Olanda 30
FR - Francia 28
VE - Venezuela 27
MA - Marocco 26
UZ - Uzbekistan 26
PK - Pakistan 24
UA - Ucraina 24
CL - Cile 23
UY - Uruguay 23
ES - Italia 22
LT - Lituania 19
SA - Arabia Saudita 19
PE - Perù 18
DZ - Algeria 17
EG - Egitto 15
KE - Kenya 15
AZ - Azerbaigian 13
BO - Bolivia 13
KZ - Kazakistan 13
TN - Tunisia 13
EU - Europa 12
AE - Emirati Arabi Uniti 11
OM - Oman 11
DO - Repubblica Dominicana 10
NP - Nepal 10
HN - Honduras 8
SN - Senegal 8
BE - Belgio 7
IR - Iran 7
MD - Moldavia 7
CR - Costa Rica 6
JM - Giamaica 6
LB - Libano 6
AL - Albania 5
AM - Armenia 5
JO - Giordania 5
KW - Kuwait 5
ET - Etiopia 4
QA - Qatar 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
IL - Israele 3
KG - Kirghizistan 3
KR - Corea 3
LV - Lettonia 3
LY - Libia 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CD - Congo 2
CH - Svizzera 2
DK - Danimarca 2
DM - Dominica 2
GA - Gabon 2
GE - Georgia 2
IM - Isola di Man 2
KH - Cambogia 2
MY - Malesia 2
NG - Nigeria 2
PA - Panama 2
Totale 18.168
Salva come PNG Salva come JPEG
Città #
Dallas 2.225
Singapore 1.185
Hong Kong 1.036
Hefei 460
Shanghai 454
Lawrence 430
Princeton 429
Ashburn 358
Ho Chi Minh City 320
Dublin 223
São Paulo 180
Helsinki 170
Hanoi 143
Beijing 134
New York 103
Milan 100
Los Angeles 71
Rio de Janeiro 71
Moscow 70
Nuremberg 57
Boardman 52
Curitiba 44
Brasília 43
Munich 41
Belo Horizonte 39
Santa Clara 37
Warsaw 35
Da Nang 34
Porto Alegre 34
Haiphong 33
Denver 32
Johannesburg 32
Tianjin 29
Salvador 28
Brooklyn 27
Tokyo 27
Campinas 26
London 26
Guayaquil 25
Stockholm 25
Pune 24
Seattle 24
Vienna 24
Atlanta 23
Poplar 23
Rome 23
Tashkent 23
Biên Hòa 22
Phoenix 22
Toronto 22
Chennai 21
Guangzhou 21
Quito 21
Baghdad 20
Orem 20
Boston 19
Caxias do Sul 19
Frankfurt am Main 19
Goiânia 19
Santo André 19
Washington 19
Guarulhos 18
Manchester 18
Montevideo 18
Osasco 18
Ribeirão Preto 18
Chicago 17
Montreal 17
Recife 17
Ankara 16
Council Bluffs 16
Fortaleza 16
Hải Dương 16
Lappeenranta 16
Turku 16
Amsterdam 15
Buenos Aires 15
Nairobi 15
San Francisco 15
Asunción 14
Formosa 14
Jakarta 14
Aracaju 13
Canoas 13
Cesano Boscone 13
Dhaka 13
Mexico City 13
Sorocaba 13
Thái Bình 13
Thái Nguyên 13
Baku 12
Bauru 12
Cape Town 12
Caracas 12
Houston 12
Joinville 12
Querétaro 12
São Bernardo do Campo 12
Campo Grande 11
Hangzhou 11
Totale 9.896
Salva come PNG Salva come JPEG
Nome #
1. Cardiac Resynchronization Therapy with Multisite Left Ventricular Pacing Improves Acute Hemodynamic Response in Patients 1.371
A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction 162
A 20-joule electrical cardioversion applied directly to the heart elevates troponin I by at least 1.5 ng.mL(-1) 116
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society 102
A Brugada Syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization 100
A controlled randomized trial of biatrial ablation for curing long-lasting permanent atrial fibrillation (the Decomplex Trial) 98
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design 98
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design 94
65. Cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure early multicenter experience 93
Ablation catheter with flexible tip and methods of making the same 88
A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White Syndrome 84
Human Sarcopenic Myoblasts Can Be Rescued by Pharmacological Reactivation of HIF-1α 82
A simple way to treat chronic atrial fibrillation during mitral valve surgery: the epicardial radiofrequency approach 82
[A methodological approach to the transcatheter radiofrequency ablation of anomalous Kent-type pathways] 81
[The physical and chemical principles of radiofrequency catheter ablation in arrhythmias] 79
[Atrioventricular conduction before and after the radiofrequency catheter ablation of a nodal reentry tachycardia circuit] 79
Challenges in Brugada Syndrome Stratification: Investigating SCN5A Mutation Localization and Clinical Phenotypes 78
Brugada Syndrome: New Insights From Cardiac Magnetic Resonance and Electroanatomical Imaging 78
Brugada syndrome genetics is associated with phenotype severity 78
“Theory and Practice of Catheter Ablation of Atrial Fibrillation. Seven different cases” 77
[Ablation of paroxysmal tachycardia in Wolff-Parkinson-White syndrome] 77
[Prospects of the treatment of atrial fibrillation. Circumferential radiofrequency ablation of pulmonary vein ostia] 75
“Cardiac Resynchronization Therapy” 73
HIF-1α Directly Controls WNT7A Expression During Myogenesis 72
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study 72
A randomized study of prophyl actic catheter ablation in high-risk children with asymptomatic Wolff-Parkinson-White syndrome 71
GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells 70
A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study 70
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 68
Brugada Syndrome: Warning of a Systemic Condition? 67
“Stroke Prevention: Left Atrial Appendage Occlusion” 67
“How to Perform Circumferential Pulmonary Vein Ablation with Electroanatomical Guidance” 66
“Circumferential Pulmonary Vein Ablation With MediGuide® System” 66
[Radiofrequency catheter ablation of atrial tachycardia: technique, results and follow-up] 66
“How to implant biventricular pacemakers in patients with heart failure” (basics and advanced techniques 65
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 64
“Management of Advanced Atrial Fibrillation” 62
Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies 62
Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC–MS: relationship between detection and stability 60
Clinical considerations for a family with dilated cardiomyopathy, sudden cardiac death, and a novel ttn frameshift mutation 60
Ebstein's anomaly in children and adults: Multidisciplinary insights into imaging and therapy 60
Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation 59
Calcium in Brugada syndrome: Questions for future research 59
Stereotaxis “Atrial Fibrillation Ablation” 58
Antitachycardia devices for the treatment of recurrent ventricular tachycardia: long term results 58
Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI) 57
The antithetic role of ceramide and sphingosine-1-phosphate in cardiac dysfunction 57
Atrial fibrillation in autoimmune rheumatic diseases: From pathogenesis to treatment 56
Course Syllabus: “Theory and Practice of Catheter Ablation of Atrial Fibrillation 2002” 55
The APAF study: A controlled randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy for curing paroxysmal atrial fibrillation: The ablation for paroxysmal atrial fibrillation (APAF) trial [Die APAF-studie: A controlled randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy for curing paroxysmal atrial fibrillation: The ablation for paroxysmal atrial fibrillation (APAF) trial] 55
Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis 54
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death 53
Management of severe cardiac arrhythmic events in elite athletes 53
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 53
Updated national multicenter registry on procedural safety of catheter ablation for atrial fibrillation 52
Novel scn5a p.Val1667asp missense variant segregation and characterization in a family with severe brugada syndrome and multiple sudden deaths 52
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 51
Long-term outcome of remote catheter ablation using a magnetic irrigated-tip catheter 50
Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram 50
Intermittent alternance of Brugada ECG patterns: Insights from a unique electrophysiological phenomenon 50
Brugada Syndrome: Oligogenic or Mendelian Disease? 50
Low incidence of permanent complications during catheter ablation for atrial fibrillation using open-irrigated catheters: A multicentre registry 50
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 49
Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome 48
Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate 48
Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome 48
Sphingolipid synthesis inhibition by myriocin administration enhances lipid consumption and ameliorates lipid response to myocardial ischemia reperfusion injury 48
Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses 47
Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation 47
Case Report: Efficacy of Rituximab in a Patient With Familial Mediterranean Fever and Multiple Sclerosis 47
Commentary: Next generation sequencing and linkage analysis for the molecular diagnosis of a novel overlapping syndrome characterized by hypertrophic cardiomyopathy and typical electrical instability of brugada syndrome 46
Quantitative assessment of left ventricular contractile synchrony during biventricular pacing using color kinesis echocardiography 46
Primary atrial tachycardia: techniques for intracardiac mapping and radiofrequency ablation 46
Fibroma of the left ventricle in a patient with Sotos syndrome 46
Atrial fibrillation in elite athletes 46
Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: The atrial fibrillation detect study 46
Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis 45
Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients 45
Dynamic programming of atrioventricular delay improves electrical synchrony in a multicenter cardiac resynchronization therapy study 45
First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: Mid-term safety and efficacy results from a multicenter study 44
False-positive noninvasive test results in hypertensives with no coronary artery disease from the stress testing hypertension (STH) trial 44
HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society 44
Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: Clinical implications from a prospective clinical trial 44
Circumferential pulmonary-vein ablation for chronic atrial fibrillation 43
Atrial Fibrillation Progression in Patients With and Without Lone Atrial Fibrillation: A Five-Year Prospective Follow-Up Study 43
High-Risk Arrhythmic presenting profile did not predict the need for defibrillation backup in cardiac resynchronization therapy patients 43
HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA) 43
SCN5A nonsense mutation and NF1 frameshift mutation in a family with brugada syndrome and neurofibromatosis 43
Feasibility of Remote Monitoring Using a Novel Long-Dipole Insertable Cardiac Monitor 43
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome 43
Control for a Remote Navigation System 42
Atrial fibrillation ablation in patients with mechanical mitral valves: safety, frasibility and outcome 42
Atrial fibrillation ablation: a realistic alternative to pharmacologic therapy 42
Palpitations: what is the mechanism, and when should we treat them? 42
Novel scn5a p.W697x nonsense mutation segregation in a family with brugada syndrome 42
Clinical outcome of electrophysiologically guided ablation for nonparoxysmal atrial fibrillation using a novel real-time 3-dimensional mapping technique results from a prospective randomized trial 42
Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation Meta-Analysis of Quality of Life, Morbidity, and Mortality 42
Electrical Substrate Elimination in 135 Consecutive Patients with Brugada Syndrome 42
Method of treating cardiac arrhythmias 41
System and methods for locating and ablating arrhythomogenic tissues 41
Totale 7.353
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.889
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 1 4 30 2 0 0 0
2021/2022176 0 0 0 92 8 9 19 3 23 2 13 7
2022/20232.266 1.075 447 106 18 6 180 224 77 83 32 14 4
2023/2024563 39 23 59 78 39 69 14 57 0 28 38 119
2024/20255.686 838 79 26 77 122 388 824 456 1.154 903 375 444
2025/20269.608 1.070 1.665 2.530 2.918 1.039 386 0 0 0 0 0 0
Totale 18.728